![]() These statements, including, without limitation, those regarding Vertexs marketed CF medicines, our pipeline and Vertexs future financial performance are based on managements current assumptions. We will make forward-looking statements on this call that are subject to the risks and uncertainties discussed in detail in todays press release and in our filings with the Securities and Exchange Commission. A replay will be available on our website. We recommend that you access the webcast slides as you listen to this call. Bastiano Sanna, Executive Vice President and Chief of Cell and Genetic Therapies at Vertex, will join us for Q&A. Reshma Kewalramani, Vertexs CEO and President Stuart Arbuckle, Chief Operating Officer and Charlie Wagner, Chief Financial Officer. On tonights call, making prepared remarks, we have Dr. Welcome to the Vertex Third Quarter 2021 Financial Results Conference Call. Michael Partridge - Senior Vice President of Investor Relations Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX) Q3 2021 Earnings Call Nov 2, 2021, 4:30 p.m.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |